Adda Nathalie
SEC CIK 1646976 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | SVP, Chief Medical Off | 67.8K | — | $12.64M | 16 | 2021-10-08 | 2022-04-01 |
Most active insiders at ENTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Luly Jay R. | Pres, CEO, Dir | — | $67.5K |
| 2 | Or Yat Sun | CSO | — | $34.0K |
| 3 | Kieffer Tara Lynn | Chief Product Strategy Off | — | $30.0K |
| 4 | Luu Brendan | Chief Business Off | — | $19.8K |
| 5 | Trout Harry R. III | See Remarks | — | $13.0K |
| 6 | Rottinghaus Scott T. | Chief Medical Off | — | $11.4K |
| 7 | Capps Kathleen S. | See Remarks | — | $7,486 |
| 8 | Kowalsky Matthew Paul | CLO | — | — |
Adda Nathalie made no open-market trades at ENTA in the last 12 months.
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-05 | 2022-04-01+ | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $40.63 | +83.3K | 67.8K | New | +$3.39M |
| DM | 2022-04-05 | 2022-04-01+ | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $71.60 | -83.3K | 35.0K | -70% | -$5.97M |
| DM | 2022-03-03 | 2022-03-01+ | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $43.46 | +36.8K | 47.5K | +346% | +$1.60M |
| DM | 2022-03-03 | 2022-03-01+ | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $70.20 | -36.8K | 35.0K | -51% | -$2.58M |
| 2022-02-15 | 2022-02-14 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | F - Tax | $62.49 | -954 | 35.0K | -3% | -$59.6K | |
| M | 2022-02-15 | 2022-02-14 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | A - Grant | $0.00 | +3,034 | 35.9K | +9% | $0 |
| D | 2022-01-13 | 2022-01-11 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $70.13 | -12.5K | 32.9K | -28% | -$879.1K |
| DM | 2022-01-13 | 2022-01-11 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $39.88 | +12.5K | 42.1K | +42% | +$499.9K |
| DM | 2021-12-03 | 2021-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $86.35 | -13.5K | 32.9K | -29% | -$1.17M |
| DM | 2021-12-03 | 2021-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $45.25 | +13.5K | 41.7K | +48% | +$611.9K |
| D | 2021-12-03 | 2021-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | F - Tax | $87.68 | -842 | 32.9K | -2% | -$73.8K |
| D | 2021-11-23 | 2021-11-19 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | A - Grant | $0.00 | +6,800 | 33.7K | +25% | $0 |
| DM | 2021-11-02 | 2021-11-01 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $84.89 | -9,547 | 26.9K | -26% | -$810.4K |
| D | 2021-11-02 | 2021-11-01 | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $48.52 | +9,547 | 36.5K | +35% | +$463.2K |
| DM | 2021-10-13 | 2021-10-08+ | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $43.46 | +17.5K | 31.0K | +130% | +$760.5K |
| DM | 2021-10-13 | 2021-10-08+ | ENTA | ENANTA PHARMACEUTICALS INC | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $70.15 | -17.5K | 26.9K | -39% | -$1.23M |
Purchase Sale Sale after option exercise All abbreviations